Correlation Between Pfizer and Cref Inflation-linked
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cref Inflation-linked at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cref Inflation-linked into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cref Inflation Linked Bond, you can compare the effects of market volatilities on Pfizer and Cref Inflation-linked and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cref Inflation-linked. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cref Inflation-linked.
Diversification Opportunities for Pfizer and Cref Inflation-linked
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Cref is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cref Inflation Linked Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cref Inflation Linked and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cref Inflation-linked. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cref Inflation Linked has no effect on the direction of Pfizer i.e., Pfizer and Cref Inflation-linked go up and down completely randomly.
Pair Corralation between Pfizer and Cref Inflation-linked
Considering the 90-day investment horizon Pfizer Inc is expected to generate 7.83 times more return on investment than Cref Inflation-linked. However, Pfizer is 7.83 times more volatile than Cref Inflation Linked Bond. It trades about 0.13 of its potential returns per unit of risk. Cref Inflation Linked Bond is currently generating about 0.23 per unit of risk. If you would invest 2,321 in Pfizer Inc on May 27, 2025 and sell it today you would earn a total of 267.00 from holding Pfizer Inc or generate 11.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Cref Inflation Linked Bond
Performance |
Timeline |
Pfizer Inc |
Cref Inflation Linked |
Pfizer and Cref Inflation-linked Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Cref Inflation-linked
The main advantage of trading using opposite Pfizer and Cref Inflation-linked positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cref Inflation-linked can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cref Inflation-linked will offset losses from the drop in Cref Inflation-linked's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Cref Inflation-linked vs. Goldman Sachs Clean | Cref Inflation-linked vs. Goldman Sachs Flexible | Cref Inflation-linked vs. James Balanced Golden | Cref Inflation-linked vs. Europac Gold Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |